NCT05316935 2025-08-11
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Fudan University
Phase 2/3 Recruiting
Clinical Trials
1 trialsPhase 2/3 × Progesterone Resistance × Cyproterone acetate, ethinyl estradiol drug combination × Clear all